Poland - Nowy Sącz: Antineoplastic and immunomodulating agents

Release

ID
ocds-pyfy63:2023-648115:2023-648115
Date
2023-10-25
Language
PL
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2023-648115
Releases
2023-10-25 (ocds-pyfy63:2023-648115:2023-648115)
2023-12-29 (ocds-pyfy63:2023-648115:2023-793963)

Releases in JSON

Tender

Title
Poland - Nowy Sącz: Antineoplastic and immunomodulating agents
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price

Award criteria for item 66:
- Price

Award criteria for item 67:
- Price

Award criteria for item 68:
- Price

Award criteria for item 69:
- Price

Award criteria for item 70:
- Price

Award criteria for item 71:
- Price

Award criteria for item 72:
- Price

Award criteria for item 73:
- Price

Award criteria for item 74:
- Price

Award criteria for item 75:
- Price

Award criteria for item 76:
- Price

Award criteria for item 77:
- Price

Award criteria for item 78:
- Price

Award criteria for item 79:
- Price

Award criteria for item 80:
- Price

Award criteria for item 81:
- Price

Award criteria for item 82:
- Price

Award criteria for item 83:
- Price

Award criteria for item 84:
- Price

Award criteria for item 85:
- Price

Award criteria for item 86:
- Price

Award criteria for item 87:
- Price

Award criteria for item 88:
- Price

Award criteria for item 89:
- Price

Award criteria for item 90:
- Price

Award criteria for item 91:
- Price
Award period
2023-11-27 - ?
Eligibility criteria
Suitability:

Wykaz i krótki opis warunków:Warunek ten zostanie spełniony, jeżeli Wykonawca wykaże, że posiada dokumenty potwierdzające posiadanie uprawnień do prowadzenia określonej działalności gospodarczej lub zawodowej tj. koncesję, zezwolenie, licencje lub wpisu do rejestru działalności regulowanej na prowadzenie hurtowni farmaceutycznej w zakresieobrotu produktami leczniczymi lub w przypadku wykonawcy prowadzącego skład konsygnacyjny- zezwolenie na jego prowadzenie.
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2023-10-25 - 2023-11-27
Value
30 274 102.29 PLN
Minimum value
30 274 102.29 PLN

Tender item

ID
ocds-pyfy63:2023-648115:obj:1
Classification
CPV / 33652000
Description
Cetuksymab

Tender item

ID
ocds-pyfy63:2023-648115:obj:2
Classification
CPV / 33652000
Description
Panitumumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:3
Classification
CPV / 33652000
Description
Aflibercep

Tender item

ID
ocds-pyfy63:2023-648115:obj:4
Classification
CPV / 33652000
Description
Triflurydyna + Typiracyl

Tender item

ID
ocds-pyfy63:2023-648115:obj:5
Classification
CPV / 33652000
Description
Ipilimumabum

Tender item

ID
ocds-pyfy63:2023-648115:obj:6
Classification
CPV / 33652000
Description
Niwolumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:7
Classification
CPV / 33652000
Description
Pembrolizumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:8
Classification
CPV / 33652000
Description
Kryzotynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:9
Classification
CPV / 33652000
Description
Ozymertynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:10
Classification
CPV / 33652000
Description
Atezolizumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:11
Classification
CPV / 33652000
Description
Afatynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:12
Classification
CPV / 33652000
Description
Nintedanib

Tender item

ID
ocds-pyfy63:2023-648115:obj:13
Classification
CPV / 33652000
Description
Alektynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:14
Classification
CPV / 33652000
Description
Cerytynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:15
Classification
CPV / 33652000
Description
Brygatynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:16
Classification
CPV / 33652000
Description
Durwalumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:17
Classification
CPV / 33652000
Description
BCG Vaccinum

Tender item

ID
ocds-pyfy63:2023-648115:obj:18
Classification
CPV / 33652000
Description
Lorlatynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:19
Classification
CPV / 33652000
Description
Entrectinibum

Tender item

ID
ocds-pyfy63:2023-648115:obj:20
Classification
CPV / 33652000
Description
Cemiplimab

Tender item

ID
ocds-pyfy63:2023-648115:obj:21
Classification
CPV / 33652000
Description
Trastuzumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:22
Classification
CPV / 33652000
Description
Lapatynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:23
Classification
CPV / 33652000
Description
Pertuzumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:24
Classification
CPV / 33652000
Description
Palbocyklib

Tender item

ID
ocds-pyfy63:2023-648115:obj:25
Classification
CPV / 33652000
Description
Rybocyklib

Tender item

ID
ocds-pyfy63:2023-648115:obj:26
Classification
CPV / 33652000
Description
Trastuzumab emtanzyna

Tender item

ID
ocds-pyfy63:2023-648115:obj:27
Classification
CPV / 33652000
Description
Abemacyklib

Tender item

ID
ocds-pyfy63:2023-648115:obj:28
Classification
CPV / 33652000
Description
Alpelisyb

Tender item

ID
ocds-pyfy63:2023-648115:obj:29
Classification
CPV / 33652000
Description
Sacytuzumab gowitekan

Tender item

ID
ocds-pyfy63:2023-648115:obj:30
Classification
CPV / 33652000
Description
Talazoparyb

Tender item

ID
ocds-pyfy63:2023-648115:obj:31
Classification
CPV / 33652000
Description
Piksantronu dimaleinian

Tender item

ID
ocds-pyfy63:2023-648115:obj:32
Classification
CPV / 33652000
Description
Polatuzumab wedotyny

Tender item

ID
ocds-pyfy63:2023-648115:obj:33
Classification
CPV / 33652000
Description
Tafasitamabum

Tender item

ID
ocds-pyfy63:2023-648115:obj:34
Classification
CPV / 33652000
Description
Ibrutynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:35
Classification
CPV / 33652000
Description
Obinutuzumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:36
Classification
CPV / 33652000
Description
Dazatynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:37
Classification
CPV / 33652000
Description
Nilotynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:38
Classification
CPV / 33652000
Description
Bosutynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:39
Classification
CPV / 33652000
Description
Ponatynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:40
Classification
CPV / 33652000
Description
Olaparyb

Tender item

ID
ocds-pyfy63:2023-648115:obj:41
Classification
CPV / 33652000
Description
Niraparyb

Tender item

ID
ocds-pyfy63:2023-648115:obj:42
Classification
CPV / 33652000
Description
Pomalidomid

Tender item

ID
ocds-pyfy63:2023-648115:obj:43
Classification
CPV / 33652000
Description
Daratumumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:44
Classification
CPV / 33652000
Description
Karfilzomib

Tender item

ID
ocds-pyfy63:2023-648115:obj:45
Classification
CPV / 33652000
Description
Iksazomib

Tender item

ID
ocds-pyfy63:2023-648115:obj:46
Classification
CPV / 33652000
Description
Elotuzumabum

Tender item

ID
ocds-pyfy63:2023-648115:obj:47
Classification
CPV / 33652000
Description
Enzalutamid

Tender item

ID
ocds-pyfy63:2023-648115:obj:48
Classification
CPV / 33652000
Description
Apalutamid

Tender item

ID
ocds-pyfy63:2023-648115:obj:49
Classification
CPV / 33652000
Description
Darolutamid

Tender item

ID
ocds-pyfy63:2023-648115:obj:50
Classification
CPV / 33652000
Description
Kabazytaksel

Tender item

ID
ocds-pyfy63:2023-648115:obj:51
Classification
CPV / 33652000
Description
Ramucyrumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:52
Classification
CPV / 33652000
Description
Blinatumomab

Tender item

ID
ocds-pyfy63:2023-648115:obj:53
Classification
CPV / 33652000
Description
Inotuzumab ozogamycyny

Tender item

ID
ocds-pyfy63:2023-648115:obj:54
Classification
CPV / 33652000
Description
Brentuksymab wedotyny

Tender item

ID
ocds-pyfy63:2023-648115:obj:55
Classification
CPV / 33652000
Description
Akalabrutynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:56
Classification
CPV / 33652000
Description
Wenetoklaks

Tender item

ID
ocds-pyfy63:2023-648115:obj:57
Classification
CPV / 33652000
Description
Ruksolitynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:58
Classification
CPV / 33652000
Description
Fedratynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:59
Classification
CPV / 33652000
Description
Paklitaksel z albuminą

Tender item

ID
ocds-pyfy63:2023-648115:obj:60
Classification
CPV / 33652000
Description
Eltrombopag

Tender item

ID
ocds-pyfy63:2023-648115:obj:61
Classification
CPV / 33652000
Description
Romiplostym

Tender item

ID
ocds-pyfy63:2023-648115:obj:62
Classification
CPV / 33652000
Description
Awatrombopag

Tender item

ID
ocds-pyfy63:2023-648115:obj:63
Classification
CPV / 33652000
Description
Midostauryna

Tender item

ID
ocds-pyfy63:2023-648115:obj:64
Classification
CPV / 33652000
Description
Gemtuzumab ozogamycyny

Tender item

ID
ocds-pyfy63:2023-648115:obj:65
Classification
CPV / 33652000
Description
Gilterytynib

Tender item

ID
ocds-pyfy63:2023-648115:obj:66
Classification
CPV / 33652000
Description
Azacytydyna

Tender item

ID
ocds-pyfy63:2023-648115:obj:67
Classification
CPV / 33652000
Description
Siltuksymab

Tender item

ID
ocds-pyfy63:2023-648115:obj:68
Classification
CPV / 33652000
Description
Denosumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:69
Classification
CPV / 33652000
Description
Luspatercept

Tender item

ID
ocds-pyfy63:2023-648115:obj:70
Classification
CPV / 33652000
Description
Interferon β-1a

Tender item

ID
ocds-pyfy63:2023-648115:obj:71
Classification
CPV / 33652000
Description
Glatirameru octan

Tender item

ID
ocds-pyfy63:2023-648115:obj:72
Classification
CPV / 33652000
Description
:Fumaran dimetylu

Tender item

ID
ocds-pyfy63:2023-648115:obj:73
Classification
CPV / 33652000
Description
Peginterferon-β-1a

Tender item

ID
ocds-pyfy63:2023-648115:obj:74
Classification
CPV / 33652000
Description
Teryflunomid

Tender item

ID
ocds-pyfy63:2023-648115:obj:75
Classification
CPV / 33652000
Description
Ofatumumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:76
Classification
CPV / 33652000
Description
Ozanimod

Tender item

ID
ocds-pyfy63:2023-648115:obj:77
Classification
CPV / 33652000
Description
Ponesimod

Tender item

ID
ocds-pyfy63:2023-648115:obj:78
Classification
CPV / 33652000
Description
Siponimod

Tender item

ID
ocds-pyfy63:2023-648115:obj:79
Classification
CPV / 33652000
Description
Fingolimod

Tender item

ID
ocds-pyfy63:2023-648115:obj:80
Classification
CPV / 33652000
Description
Natalizumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:81
Classification
CPV / 33652000
Description
Okrelizumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:82
Classification
CPV / 33652000
Description
Kladrybina

Tender item

ID
ocds-pyfy63:2023-648115:obj:83
Classification
CPV / 33652000
Description
Alemtuzumab

Tender item

ID
ocds-pyfy63:2023-648115:obj:84
Classification
CPV / 33652000
Description
Interferon β-1a

Tender item

ID
ocds-pyfy63:2023-648115:obj:85
Classification
CPV / 33652000
Description
:Interferon β-1b

Tender item

ID
ocds-pyfy63:2023-648115:obj:86
Classification
CPV / 33652000
Description
:Immunoglobulinum humanum

Tender item

ID
ocds-pyfy63:2023-648115:obj:87
Classification
CPV / 33652000
Description
Netupitantum + Palonosetroni hydrochloridum

Tender item

ID
ocds-pyfy63:2023-648115:obj:88
Classification
CPV / 33652000
Description
Epirubicin

Tender item

ID
ocds-pyfy63:2023-648115:obj:89
Classification
CPV / 33652000
Description
Azacytydyna

Tender item

ID
ocds-pyfy63:2023-648115:obj:90
Classification
CPV / 33652000
Description
Rytuksymab

Tender item

ID
ocds-pyfy63:2023-648115:obj:91
Classification
CPV / 33652000
Description
Denosumab

Parties

Roles
buyer
Organization name
Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Street address
ul. Młyńska 10
Locality
Nowy Sącz
Postal code
33-300
Country
PL
Contact name
Ryszard Tobiasz
E-mail
zamowieniapubliczne@szpitalnowysacz.pl
Phone
+48 184436635
Fax
+48 184436635
Website
www.szpitalnowysacz.pl

Organization data Organization in JSON